The goal of this clinical trial is to learn about the effectiveness of extracorporeal shockwave(ESWT) combined with platelet-rich plasma(PRP) to treat chronic insertional tendinopathy. The main questions it aims to answer are:
Does ESWT combined with PRP treatment reduce the symptom and improve functional score after treatment? What medical complication do participants have when receive the treatment?
Researchers will compare ESWT combined with PRP to ESWT treatment alone to see if ESWT combined with PRP works to treat chronic insertional tendinopathy.
Participants will:
* Receive ESWT once a week for 4 weeks then receive PRP injection at a week later or ESWT once a week for 4 weeks * Visit the clinic at 6 weeks, 3 months, 6 months and 1 year after treatment for checkups and record functional score
Diagnosed with insertional Achilles tendinopathy
Had symptom more than 6 months
Failed other standard conservative treatment (rest, medication, activity modification, stretching exercise, and heel lift orthosis)
Receive corticosteroid injection at the Achilles insertion
History of infection around ankle and heel
Has neurological deficit
Has a contraindication for ESWT(hemophilia, coagulopathy or foot and ankle malignancy)
Parallel
ESWT
DeviceReceive ESWT once a week for 4 weeks
PRP
Biological/VaccineReceive PRP injection at week 5
VAS
Visual Analogue Scale
VAS-FA
Visual analogue scale foot and ankle
FFI
Foot functional index
FAAM
Foot and Ankle Ability Measure
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options:
